Biopsy guidance system gets FDA nod
This article was originally published in Clinica
The US FDA has granted 510(k) clearance for GammaLoc, a lesion localisation system developed by Dilon Diagnostics for molecular imaging biopsy guidance. The system is designed to help doctors locate breast lesions and enable gamma-guided biopsies. The portable device compliments Dilon’s lead product, the Dilon 6800 Gamma Camera, the Newport News, Virginia firm said.
Register for our free email digests: